New Minimal Residual Disease Assessment Could Detect Disease Progression Earlier in MM
AJMC,
Flow–minimal residual disease (MRD) assessment in patients with multiple myeloma (MM) was found to be a good tool for early…
Flow–minimal residual disease (MRD) assessment in patients with multiple myeloma (MM) was found to be a good tool for early…
A substudy of the European‐Myeloma-Network‐02/Hovon‐95 trial suggests flow cytometry–based monitoring of minimal residual…